Lexim AI

Lexim AI has released a new regulatory analysis identifying the most common compliance gaps observed in medical device inspections conducted by the U.S. Food and Drug Administration (FDA).

Lexim.AI today announced the formal launch of its AI-Powered Internal Audits framework, a structured, compliance-aligned solution designed to modernize internal audit functions across pharmaceutical, biotechnology.

AI regulatory intelligence is no longer optional—platforms like Lexim AI enable proactive, efficient, and compliant regulatory strategy across pharma, biotech, medical devices, and digital health.